Extracellular Vesicles from Cryptococcus neoformans Modulate Macrophage Functions

ABSTRACT Cryptococcus neoformans and distantly related fungal species release extracellular vesicles that traverse the cell wall and contain a varied assortment of components, some of which have been associated with virulence. Previous studies have suggested that these extracellular vesicles are produced in vitro and during animal infection, but the role of vesicular secretion during the interaction of fungi with host cells remains unknown. In this report, we demonstrate by fluorescence microscopy that mammalian macrophages can incorporate extracellular vesicles produced by C. neoformans. Incubation of cryptococcal vesicles with murine macrophages resulted in increased levels of extracellular tumor necrosis factor alpha (TNF-α), interleukin-10 (IL-10), and transforming growth factor β (TGF-β). Vesicle preparations also resulted in a dose-dependent stimulation of nitric oxide production by phagocytes, suggesting that vesicle components stimulate macrophages to produce antimicrobial compounds. Treated macrophages were more effective at killing C. neoformans yeast. Our results indicate that the extracellular vesicles of C. neoformans can stimulate macrophage function, apparently activating these phagocytic cells to enhance their antimicrobial activity. These results establish that cryptococcal vesicles are biologically active.

[1]  Y. Gho,et al.  Gram‐positive bacteria produce membrane vesicles: Proteomics‐based characterization of Staphylococcus aureus‐derived membrane vesicles , 2009, Proteomics.

[2]  A. Casadevall,et al.  Vesicle-associated melanization in Cryptococcus neoformans. , 2009, Microbiology.

[3]  A. Casadevall,et al.  Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. , 2009, Fungal genetics and biology : FG & B.

[4]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[5]  A. Casadevall,et al.  Lipophilic Dye Staining of Cryptococcus neoformans Extracellular Vesicles and Capsule , 2009, Eukaryotic Cell.

[6]  A. Casadevall,et al.  Vesicular transport across the fungal cell wall. , 2009, Trends in microbiology.

[7]  Bruce A. Stanton,et al.  Long-Distance Delivery of Bacterial Virulence Factors by Pseudomonas aeruginosa Outer Membrane Vesicles , 2009, PLoS pathogens.

[8]  A. Casadevall,et al.  Sec6‐dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans , 2009, Molecular microbiology.

[9]  A. Casadevall,et al.  The capsule of the fungal pathogen Cryptococcus neoformans. , 2009, Advances in applied microbiology.

[10]  A. Casadevall,et al.  Capsular Localization of the Cryptococcus neoformans Polysaccharide Component Galactoxylomannan , 2008, Eukaryotic Cell.

[11]  A. Casadevall,et al.  Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival , 2008, Cellular microbiology.

[12]  S. Levitz,et al.  Cryptococcus neoformans Enters the Endolysosomal Pathway of Dendritic Cells and Is Killed by Lysosomal Components , 2008, Infection and Immunity.

[13]  A. Casadevall,et al.  Fungal killing by mammalian phagocytic cells. , 2008, Current opinion in microbiology.

[14]  A. Casadevall,et al.  Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans‐cell wall transfer of proteins and lipids in ascomycetes , 2008, Cellular microbiology.

[15]  A. Casadevall,et al.  A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis , 2008, Communicative & integrative biology.

[16]  L. Pirofski,et al.  Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan , 2008, Clinical and Vaccine Immunology.

[17]  C. Takiya,et al.  Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand , 2008, Cellular microbiology.

[18]  Kazuo Suzuki,et al.  Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG‐oligodeoxynucleotide‐stimulated macrophages in a fashion independent of capsular polysaccharides , 2008, Microbiology and immunology.

[19]  A. Casadevall,et al.  Binding of the Wheat Germ Lectin to Cryptococcus neoformans Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular Glucuronoxylomannan , 2007, Eukaryotic Cell.

[20]  A. Casadevall,et al.  Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated with Virulence , 2007, Eukaryotic Cell.

[21]  J. Xiang,et al.  Review: cancer immunotherapy by exosome-based vaccines. , 2007, Cancer biotherapy & radiopharmaceuticals.

[22]  A. Casadevall,et al.  Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages , 2007, BMC Immunology.

[23]  R. May,et al.  Direct cell-to-cell spread of a pathogenic yeast , 2007, BMC Immunology.

[24]  B. Phinney,et al.  Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans. , 2007, FEMS yeast research.

[25]  Arturo Casadevall,et al.  Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport , 2006, Eukaryotic Cell.

[26]  A. Casadevall,et al.  Phagosome Extrusion and Host-Cell Survival after Cryptococcus neoformans Phagocytosis by Macrophages , 2006, Current Biology.

[27]  R. May,et al.  Expulsion of Live Pathogenic Yeast by Macrophages , 2006, Current Biology.

[28]  S. Levitz,et al.  Direct Inhibition of T-Cell Responses by the Cryptococcus Capsular Polysaccharide Glucuronoxylomannan , 2006, PLoS pathogens.

[29]  S. Almeida,et al.  Nitric oxide‐dependent killing of Cryptococcus neoformans by B‐1‐derived mononuclear phagocyte , 2006, Journal of leukocyte biology.

[30]  M. Kuehn,et al.  Bacterial outer membrane vesicles and the host-pathogen interaction. , 2005, Genes & development.

[31]  M. Del Poeta,et al.  Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor. , 2005, The Biochemical journal.

[32]  A. Casadevall,et al.  Cryptococcus neoformans Capsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages1 , 2005, The Journal of Immunology.

[33]  A. Casadevall,et al.  Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. , 2005, The Journal of infectious diseases.

[34]  D. Lefeber,et al.  O-Acetylation of Cryptococcal Capsular Glucuronoxylomannan Is Essential for Interference with Neutrophil Migration1 , 2004, The Journal of Immunology.

[35]  H. Rubinstein,et al.  Immunosuppression, interleukin‐10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan , 2004, Immunology.

[36]  M. Puliti,et al.  Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Inhibits the Progression of Group B Streptococcal Arthritis , 2004, Infection and Immunity.

[37]  M. Del Poeta.  Role of Phagocytosis in the Virulence of Cryptococcus neoformans , 2004, Eukaryotic Cell.

[38]  M. Khorramizadeh,et al.  Tolerability and Anti‐Inflammatory Effects of Glucuronoxylomannan in Collagen‐Induced Arthritis , 2004, Scandinavian journal of immunology.

[39]  P. Ellerbroek,et al.  Cryptococcal glucuronoxylomannan interferes with neutrophil rolling on the endothelium , 2004, Cellular microbiology.

[40]  A. Casadevall,et al.  The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation , 2003, Journal of leukocyte biology.

[41]  A. Casadevall,et al.  The efficacy of complement‐mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3‐mediated interactions , 2003, European journal of immunology.

[42]  M. Schaller,et al.  The Secreted Aspartyl Proteinases Sap1 and Sap2 Cause Tissue Damage in an In Vitro Model of Vaginal Candidiasis Based on Reconstituted Human Vaginal Epithelium , 2003, Infection and Immunity.

[43]  G. DosReis,et al.  Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. , 2003 .

[44]  Regis Mariano Andrade,et al.  Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. , 2003, Cellular immunology.

[45]  E. Amankwah,et al.  Primary Dendritic Cells Phagocytose Cryptococcus neoformans via Mannose Receptors and Fcγ Receptor II for Presentation to T Lymphocytes , 2002, Infection and Immunity.

[46]  F. Bistoni,et al.  Modulation of C5aR Expression on Human Neutrophils by Encapsulated and Acapsular Cryptococcus neoformans , 2002, Infection and Immunity.

[47]  A. Casadevall,et al.  Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Bauman,et al.  Differences in Components at Delayed-Type Hypersensitivity Reaction Sites in Mice Immunized with Either a Protective or a Nonprotective Immunogen of Cryptococcus neoformans , 2002, Infection and Immunity.

[49]  A. Casadevall,et al.  Host-pathogen interactions: the attributes of virulence. , 2001, The Journal of infectious diseases.

[50]  A. Casadevall,et al.  Intracellular parasitism of macrophages by Cryptococcus neoformans. , 2001, Trends in microbiology.

[51]  R. Schnaar,et al.  Segregation of Gangliosides GM1 and GD3 on Cell Membranes, Isolated Membrane Rafts, and Defined Supported Lipid Monolayers , 2001, Biological chemistry.

[52]  K. Kawakami,et al.  NK Cells Eliminate Cryptococcus neoformans by Potentiating the Fungicidal Activity of Macrophages Rather than by Directly Killing Them upon Stimulation with IL‐12 and IL‐18 , 2000, Microbiology and immunology.

[53]  E. Jacobson.  Pathogenic roles for fungal melanins. , 2000, Clinical microbiology reviews.

[54]  A. Casadevall,et al.  Urease as a Virulence Factor in Experimental Cryptococcosis , 2000, Infection and Immunity.

[55]  P. Williamson,et al.  Laccase Protects Cryptococcus neoformansfrom Antifungal Activity of Alveolar Macrophages , 1999, Infection and Immunity.

[56]  A. Casadevall,et al.  Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans. , 1999, AIDS.

[57]  H. Okamura,et al.  Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. , 1999, Cellular immunology.

[58]  L. Travassos,et al.  Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms. , 1999, Microbes and infection.

[59]  D. Masih,et al.  Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis. , 1999, Clinical immunology.

[60]  U. Reichard,et al.  Aspergillus fumigatus-secreted proteases as antigenic molecules and virulence factors. , 1999, Contributions to microbiology.

[61]  T. Kozel,et al.  Cryptococcus neoformans and Candida albicans regulate CD4 expression on human monocytes. , 1998, The Journal of infectious diseases.

[62]  A. Casadevall,et al.  Antigen-Induced Protective and Nonprotective Cell-Mediated Immune Components against Cryptococcus neoformans , 1998, Infection and Immunity.

[63]  W. Chaffin,et al.  Cell Wall and Secreted Proteins ofCandida albicans: Identification, Function, and Expression , 1998, Microbiology and Molecular Biology Reviews.

[64]  A. Beauvais,et al.  Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans , 1997, Infection and immunity.

[65]  J. Murphy,et al.  Cryptococcal polysaccharides bind to CD18 on human neutrophils , 1997, Infection and immunity.

[66]  A. Casadevall,et al.  J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. , 1996, The Journal of infectious diseases.

[67]  J. Verhoef,et al.  Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry , 1995, Clinical and diagnostic laboratory immunology.

[68]  T. Beccari,et al.  Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes , 1995, Infection and immunity.

[69]  A. Casadevall,et al.  Virulence: Mechanism of Action. Cryptococcus Neoformans Melanin And , 1995 .

[70]  T. Beveridge,et al.  Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion , 1995, Journal of bacteriology.

[71]  J. Douwes,et al.  Influence of various dust sampling and extraction methods on the measurement of airborne endotoxin , 1995, Applied and environmental microbiology.

[72]  D. Granger,et al.  Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells , 1995, Infection and immunity.

[73]  J. Latgé,et al.  Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus , 1994, Infection and immunity.

[74]  T. G. Mitchell,et al.  Killing of Cryptococcus neoformans strains by human neutrophils and monocytes , 1991, Infection and immunity.

[75]  M. A. Wilson,et al.  Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins , 1989, Infection and immunity.

[76]  T. Kozel,et al.  Role of the capsule in phagocytosis of Cryptococcus neoformans. , 1988, Reviews of infectious diseases.

[77]  L. Travassos,et al.  Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen , 1986, Infection and immunity.

[78]  T. Kozel,et al.  Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast , 1986, Infection and immunity.

[79]  R. Cherniak,et al.  Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. , 1985, Current topics in medical mycology.

[80]  T. Kozel,et al.  Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils , 1984, Infection and immunity.

[81]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[82]  E. Jacobson,et al.  Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans , 1982, Journal of bacteriology.

[83]  G. Bulmer,et al.  Cryptococcus neoformans III. Inhibition of Phagocytosis , 1968 .